Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

320.00p
   
  • Change Today:
      16.50p
  • 52 Week High: 445.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 106.00m
  • Volume: 159,159
  • Market Cap: £339.20m
  • RiskGrade: 125
  • Beta: 0.01

Oxford Biomedica signs licence, supply deal with Cabaletta Bio

By Frank Prenesti

Date: Wednesday 05 Jan 2022

LONDON (ShareCast) - (Sharecast News) - Gene and cell therapy group Oxford Biomedica on Wednesday said it had signed a new license and supply agreement on its LentiVector platform with US-based Cabaletta Bio.
The deal gives Cabaletta a non-exclusive licence for LentiVector to be used on Chimeric autoantibody receptor T programme, DSG3-CAART, for autoimmune disease.

No financial details were revealed, but Oxford Biomendica said the arrangements of the LSA were "in line with comparable deals the group has previously secured".





Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 320.00p
Change Today 16.50p
% Change 5.44 %
52 Week High 445.00
52 Week Low 232.50
Volume 159,159
Shares Issued 106.00m
Market Cap £339.20m
Beta 0.01
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.79% below the market average30.79% below the market average30.79% below the market average30.79% below the market average30.79% below the market average
2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average
Price Trend
44.7% below the market average44.7% below the market average44.7% below the market average44.7% below the market average44.7% below the market average
6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average
Income Not Available
Growth
1.95% above the market average1.95% above the market average1.95% above the market average1.95% above the market average1.95% above the market average
3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 23-May-2025

Time Volume / Share Price
16:26 1 @ 321.00p
16:17 170 @ 320.50p
16:17 2 @ 322.00p
16:17 184 @ 321.00p
16:13 29 @ 321.50p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page